Cover Image

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine

The continuous evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants poses a challenge to determine the optimal updated composition of the coronavirus disease 2019 (COVID-19) vaccine. The present study aimed to investigate the immunogenicity of the Delta monovalent vacci...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wanting Li (Author), Tiantian Zhao (Author), Bai Tao (Author), Liwei Zhao (Author), Hang Xiao (Author), Xinyu Ding (Author), Chuang Li (Author), Lin Chen (Author), Hao Cheng (Author), Yang Lou (Author), Yuxin Chen (Author), Chao Wu (Author)
Format:	Book
Published:	Taylor & Francis Group, 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection
by: Jin-Jin Chen, et al.
Published: (2023)

Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
by: Rachael Pung, et al.
Published: (2023)

The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan
by: Jih-Jin Tsai, et al.
Published: (2024)

Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand
by: Karan Thakkar, et al.
Published: (2023)

Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia
by: Karan Thakkar, et al.
Published: (2023)

Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
by: Xiaosu Chen, et al.
Published: (2023)

COVID-19 hospitalisations in a tertiary health service during the Omicron subvariant wave
by: Alysha Y. Wanigaratne, et al.
Published: (2024)

Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau
by: Cong Xu, et al.
Published: (2023)

Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study
by: Cheng Cao, et al.
Published: (2023)

An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
by: Meiling Zhang, et al.
Published: (2022)

Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review
by: Pradipta Paul, et al.
Published: (2023)

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
by: Srijan Chatterjee, et al.
Published: (2023)

Clinical Profile and Outcome Analysis of Ear-Nose-Throat Symptoms in SARS-CoV-2 Omicron Subvariant Infections
by: Yixuan Liu, et al.
Published: (2023)

Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants
by: Weiyu Peng, et al.
Published: (2023)

Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variants
by: Qidong Hu, et al.
Published: (2022)

The impact of vaccination on patients with COVID-19 during the wave of Omicron in Shanghai
by: Chen Yu, et al.
Published: (2022)

Primary and booster vaccination in reducing severe clinical outcomes associated with Omicron Naïve infection
by: Chen-Yang Hsu, et al.
Published: (2023)

An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA
by: Mohammad Tabatabai, et al.
Published: (2023)

How to control the spatiotemporal spread of Omicron in the region with low vaccination rates
by: Chengzhuo Tong, et al.
Published: (2022)

Vaccine apartheid: the separation of the world's poorest and most vulnerable and the birth of Omicron
by: Sakshi Prasad, et al.
Published: (2022)

Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves
by: Bernardo Valdivieso-Martinez, et al.
Published: (2024)

Omicron! Alert for dental surgeons
by: S M Balaji
Published: (2021)

Omicron: A Blessing in Disguise?
by: Esayas Kebede Gudina, et al.
Published: (2022)

Omicron: An emerging variant of concern
by: Vasantha Kamath, et al.
Published: (2022)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
by: Ren Xu, et al.
Published: (2022)

Prevalence of SARS-CoV-2 Omicron variants and epidemiological characteristics of subvariant XBB infections in Pudong New Area, Shanghai during January - June 2023
by: Yilin JIA, et al.
Published: (2023)

Policy choices for Shanghai responding to challenges of Omicron
by: Ying Qian, et al.
Published: (2022)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2022)

Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
by: Tananya Lokanuwatsatien, et al.
Published: (2023)

Omicron COVID-19 variant outcomes and vaccination in non-severe and non-critical patients at admission
by: Hong Zhao, et al.
Published: (2023)

Efficacy of Omicron variant as a natural vaccine for COVID19 & probabilities to produce synthetic vaccines
by: Hethesh Chellapandian, et al.
Published: (2023)

COVID-19 vaccination coverage in hypertensive patients with Omicron infection: Comments on factors
by: Hinpetch Daungsupawong, et al.
Published: (2023)

Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico
by: Lenin Domínguez-Ramírez, et al.
Published: (2022)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
by: Chiranjib Chakraborty, et al.
Published: (2023)

Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak
by: Wenjing Ye, et al.
Published: (2023)

Effectiveness of vaccination in reducing hospitalization and mortality rates in dialysis patients with Omicron infection in China: A single-center study
by: Quanchao Zhang, et al.
Published: (2023)

Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates
by: Alexander L Lundberg, et al.
Published: (2022)

Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway
by: Arild Iversen, et al.
Published: (2024)

Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile
by: Andrea Mella-Torres, et al.
Published: (2022)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
by: A Reum Kim, et al.
Published: (2023)